Search research articles
Contact Us
Filters
Showing results (281-290 of 511) with videos related to
Page
of 52
Sort By:
Frontiers in Microbiology
|
December 9, 2021
Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
Tilman G Schultze, Philip G Ferstl, David Villinger, et al.
European Radiology Experimental
|
May 31, 2019
Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model
Julian A Luetkens, Sabine Klein, Frank Träber, et al.
United European Gastroenterology Journal
|
February 26, 2026
Same Session Validation of a Custom-Built 22G With the Commercial 25G System for EUS-Guided Portal Pressure Gradient Measurement
Michael Praktiknjo, Nancy Farouk, Zeyu Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2019
Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis
Jennifer Lehmann, Michael Praktiknjo, Mette Juul Nielsen, et al.
Hepatology Communications
|
April 16, 2019
Left Ventricular Longitudinal Contractility Predicts Acute-on-Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt
Christian Jansen, Anna Schröder, Robert Schueler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 7, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality
Jennifer M Lehmann, Karina Claus, Christian Jansen, et al.
Gastroenterology
|
May 20, 2015
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
Tilman Sauerbruch, Martin Mengel, Matthias Dollinger, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
February 4, 2012
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
Alexandra Wojtalla, Frank Herweck, Michaela Granzow, et al.
Hepatology Communications
|
December 5, 2023
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
Thit M Kronborg, Robert Schierwagen, Kajetan Trošt, et al.
Scientific Reports
|
February 21, 2019
Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats
Sabine Klein, Franziska Frohn, Fernando Magdaleno, et al.
Page
of 52
Search research articles
Search
Showing results (281-290 of 511) with videos related to
Sort By:
Page
of 52
Frontiers in Microbiology
|
December 9, 2021
Molecular Surveillance of Carbapenem-Resistant Gram-Negative Bacteria in Liver Transplant Candidates
Tilman G Schultze, Philip G Ferstl, David Villinger, et al.
European Radiology Experimental
|
May 31, 2019
Quantification of liver fibrosis: extracellular volume fraction using an MRI bolus-only technique in a rat animal model
Julian A Luetkens, Sabine Klein, Frank Träber, et al.
United European Gastroenterology Journal
|
February 26, 2026
Same Session Validation of a Custom-Built 22G With the Commercial 25G System for EUS-Guided Portal Pressure Gradient Measurement
Michael Praktiknjo, Nancy Farouk, Zeyu Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 11, 2019
Collagen type IV remodelling gender-specifically predicts mortality in decompensated cirrhosis
Jennifer Lehmann, Michael Praktiknjo, Mette Juul Nielsen, et al.
Hepatology Communications
|
April 16, 2019
Left Ventricular Longitudinal Contractility Predicts Acute-on-Chronic Liver Failure Development and Mortality After Transjugular Intrahepatic Portosystemic Shunt
Christian Jansen, Anna Schröder, Robert Schueler, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 7, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality
Jennifer M Lehmann, Karina Claus, Christian Jansen, et al.
Gastroenterology
|
May 20, 2015
Prevention of Rebleeding From Esophageal Varices in Patients With Cirrhosis Receiving Small-Diameter Stents Versus Hemodynamically Controlled Medical Therapy
Tilman Sauerbruch, Martin Mengel, Matthias Dollinger, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
February 4, 2012
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
Alexandra Wojtalla, Frank Herweck, Michaela Granzow, et al.
Hepatology Communications
|
December 5, 2023
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
Thit M Kronborg, Robert Schierwagen, Kajetan Trošt, et al.
Scientific Reports
|
February 21, 2019
Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats
Sabine Klein, Franziska Frohn, Fernando Magdaleno, et al.
Page
of 52